Showing results (21-30 of 407) with videos related to

Sort By:
Pageof 41
World Journal of Gastroenterology|October 30, 2019
Gut-liver axis signaling in portal hypertensionBenedikt Simbrunner, Mattias Mandorfer, Michael Trauner, et al.
Hepatology (Baltimore, Md.)|September 19, 2025
Bile acid signaling in MASLD: From pathogenesis to therapeutic applicationsBenedikt Simbrunner, Rafael Paternostro, Thomas Reiberger, et al.
Faculty Reviews|June 16, 2021
Recent advances in the understanding and management of hepatorenal syndromeBenedikt Simbrunner, Michael Trauner, Thomas Reiberger, et al.
Seminars in Liver Disease|July 18, 2019
Vascular Targets for the Treatment of Portal HypertensionKsenia Brusilovskaya, Philipp Königshofer, Philipp Schwabl, et al.
Journal of Hepatology|July 6, 2021
Polyploidy control in hepatic health and diseaseValentina C Sladky, Felix Eichin, Thomas Reiberger, et al.
Hepatology International|April 15, 2026
Impact of pharmacological sGC stimulation with Riociguat in experimental models of liver disease regressionKatharina Bonitz, Philipp Königshofer, Henriette Horstmeier, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 10, 2023
Carvedilol as the new non-selective beta-blocker of choice in patients with cirrhosis and portal hypertensionLaura Turco, Thomas Reiberger, Giovanni Vitale, et al.
Wiener Klinische Wochenschrift|June 11, 2026
Evolution of liver disease severity and portal hypertension during REP 2139-Mg treatment in 3 patients with chronic hepatitis D : Case reportsMathias Jachs, Michael Schwarz, Mattias Mandorfer, et al.
The Lancet. Gastroenterology & Hepatology|August 8, 2025
Recompensation in decompensated cirrhosisMadhumita Premkumar, Patrick S Kamath, Thomas Reiberger, et al.
Pageof 41